Healthcare - Events

The 20th Clinical Research Billing Compliance Summit brings together compliance officers, billing specialists, and research leaders to share strategies, updates, and best practices for accurate, audit-ready billing. Learn from experts, join workshops, and network with peers February 23-25, 2026 in New Orleans. Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Clinical Date and Time: 23rd February 2026 at 9:00 am to 25th February 2026 at 5:00 pm Venue details: New Orleans Marriott Warehouse Arts District, 859 Convention Center Boulevard, New Orleans, Louisiana, 70130, United States

Uniting 100+ leaders from cutting-edge biotechs to global pharma, this summit delivers comprehensive insight across antigen selection, biomarker strategy, B-cell and cellular tolerance mechanisms, delivery platforms, and clinical trial execution. The 2026 agenda spotlights late-stage data from Topas, Diamyd, and COUR; novel mRNA- LNP approaches from Moderna; integrated nanotherapeutics; and next-generation Treg and tolerance-restoring strategies. Key sessions explore central versus peripheral tolerance, and how gene and cell therapy are redefining therapeutic durability and safety. Now in its ninth year, the 9th Antigen-Specific Immune Tolerance Summit remains the only end-to-end meeting dedicated to advancing antigen-specific immune tolerance. Join Pfizer, Moderna, AbbVie, Diamyd, COUR, a…

The 6th TPD and Induced Proximity Summit Europe is the only European forum dedicated exclusively to proximity-based drug discovery. From PROTACs and molecular glues to stabilizers and extracellular degraders, this summit showcases the full spectrum of therapeutic innovation across oncology, neurodegeneration, immunology, and rare diseases. Held in London in March 2026, the event brings together more than 80 CxOs, directors, senior scientists and investors to accelerate proximity therapeutics from discovery to clinic. Europe is experiencing a surge in strategic investment and innovation, including Sanofi’s acquisition of Blueprint Medicines for £7.2 billion and Merck’s £2.7 billion purchase of SpringWorks Therapeutics. As the region pivots toward non-oncology indications and novel mechanism…

Dear Colleagues It is our pleasure to welcome you to the 19th International Conference on Advanced Technologies and Treatments (ATTD 2026) taking place at the fascinating city of Barcelona, on March 11-14, 2026. Join us at ATTD 2026, the premier international platform where a diverse community - clinicians, diabetes care providers, researchers, industry, startups, investors, reimbursement authorities, and regulators - collaborates to drive rapid progress in diabetes care. The conference program features presentations and discussions led by distinguished professionals, covering a wide spectrum of innovations from artificial intelligence and glucose technology to novel therapies and prevention strategies. We look forward to your contributions and active participation, which will be instrumen…

Healthcare is changing faster than we can reactCompanies have had to make billion-dollar bets on AI, manufacturing, organizational models and CRM systems, going against decades of waiting for clarity before committing. But clarity isn't coming, and patients can't wait. Nor can we. It's time to stop predicting the future and prepare for all futures. What works across all of them? Patient-centricity and cross-functionality. Cross-functionality unlocks trapped capabilities. Functional excellence without structural integration fails in today's efficiency-first world. When Medical and Commercial align, omnichannel delivers and launches accelerate. Coordination that consumed months compresses into days. World-class skills finally operate at world-class velocity, built on the technology stacks an…

Novel conjugates have become one of the most competitive and rapidly evolving areas in the precision oncology landscape. Companies are looking beyond traditional ADCs towards novel mechanism of action payloads and differentiated targeting formats for overcoming drug resistance, improved therapeutic windows and to make an impact in cancers which don’t respond to traditional ADCs, as well as the exploration of non-oncology indications. The 5th Novel Conjugates Summit is the industry’s only dedicated meeting for an insider view into which novel approaches are currently being explored, what benefit each approach has and the directions the space is heading. Attendees gain valuable competitive insight into emerging technologies, early data, and the rationale behind each approach, from establishe…

The Annual Pharma Supply Chain & Security World Summit is back in London for the 8th time, and this time with more focus on optimising your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance…

The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment. Key Topics Include:  Transform S&OP into IBP to Connect Strategy, Finance, and Execution Cross Functional Collaboration – Key for Successful S&OP/IBP Balance Short- and Long-Term Planning to Enable Strategic Alignment Leverage AI and Data to Strengthen S&OP and IBP Foundations Drive Change Management to Advance S&OP and IBP Maturity Align Portfolio and Demand to Build a Single Planni…

Join leading experts at the Pediatrics and Neonatology Conference to explore the latest advancements in child healthcare, pediatric research, and neonatal medicine. The event covers innovative treatments, clinical practices, and emerging pediatric technologies.

The 11th Innate Killer Summit continues its legacy as the world's leading industry meeting dedicated exclusively to advancing NK and innate immune cell therapies. This year, the summit unites pioneering biotechs, including NKGen, NKILT, Senti Bio, NKore, and leaders from the MD Anderson Rizvani Lab, alongside translational scientists and platform innovators to showcase breakthrough progress in engineering, manufacturing, persistence, tumor targeting, and clinical translation. As the NK space becomes increasingly competitive and the path to differentiation narrows, this summit stands firmly alongside the global NK community, providing the clarity, collaboration, and momentum needed to keep innovation moving forward. With in-depth scientific content, real-world clinical insights across six c…

The 8th CRISPR AgBio Congress is the leading forum for AgBiotech innovators, seed companies, growers, consumer food brands, and investors to accelerate the commercialization of gene-edited crops. With USDA easing regulatory pathways and AI revolutionizing trait discovery, now is the time to position your organization at the forefront of sustainable agriculture. Join industry leaders, including Pairwise, Corteva, Bayer Crop Science, BASF, and more to explore next-generation CRISPR tools, AI-driven target discovery, and strategies for navigating global regulations. New for 2026: Global Regulations and IP Focus Day, a dedicated Driving Consumer Acceptance Panel, and expanded sessions on AI applications in AgBio. Be part of the only event combining technical breakthroughs with commercial know-…

Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams who remain steadfast in their belief that this science can transform lives. Confidence is returning, with significant investments and acquisitions signalling a renewed commitment to overcoming barriers of safety, efficacy, and scalability. The 9th Gene Therapy Development Summit returns to Boston as the meeting point for this community. Join 100+ leading voices from the likes of Bayer, Astellas Pharmaceuticals, REGENXBIO, Ocugen, AskBio, CureDuchenne Ventures, and more to come together to share ideas, restore confidence, and chart a sustainable path forward for gene therapy. Connect with your peers in pre-clinical development, manufacturing, analy…

The International Conference on Cardiology and Cardiovascular Science will take place from March 26-28, 2026, in Singapore and online, providing a unique opportunity for medical professionals, academics, and industry leaders to engage in high-level discussions on cardiac health. With sessions in Cardiology Conferences 2026 covering everything from advancements in cardiac electrophysiology to the role of AI in diagnosing cardiovascular diseases, these Cardiology Conferences are set to shape the future of heart disease prevention and treatment. By attending Cardiology Conference, participants will benefit from exposure to the latest research, practical training sessions, and exclusive networking opportunities with top-tier cardiologists and medical innovators. The Cardiovascular Science Conf…

LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers Squibb/Orbital Therapeutics. Validating LNPs as a stand-out delivery vehicle for cell and gene therapies! Returning to Boston in April 2026, the 5th LNP Formulation and Process Development Summit is an industry-led end-to-end meeting providing the latest scientific content to advance LNP development for a variety of payloads and therapeutic applications, from mRNA vaccines to next-generation cell and gene therapies. This is your one-stop shop to hear insights on LNP discovery, analytics, formulation, process development and large-scale manufacturing. With 3 focused streams, Analytical Development and…

EDUCATION IS OUR TOP PRIORITY!With education documentation becoming a way of life and the budget constraints facing many hospitals and institutions, in conjunction with the Society of Interventional Radiology (SIR) and the Association for Radiologic and Imaging Nursing (ARIN), AVIR strives to build an education program that meets and exceeds the expectations of our attendees. The AVIR Annual Scientific Meeting continues to provide an excellent venue for participation and marketing for our corporate sponsors. AVIR MISSIONis to grow, advance, and continue education in the area of vascular and interventional radiology and to promote professional growth and resources for AVIR members throughout the medical community.The AVIR is comprised of department managers, chief technologists, directors a…

Thought Leader Texas is a premier gathering for executives, innovators, and industry leaders who want to stay ahead of fast-moving shifts in business, leadership, and organizational strategy. This summit brings together experts from across sectors to share fresh perspectives, practical insights, and proven approaches that help leaders navigate today’s most pressing challenges. Through keynote talks, panel discussions, and interactive sessions, attendees will explore themes such as leadership development, talent and culture, operational excellence, technology adoption, and long-term strategic growth. Each session is designed to offer actionable takeaways-clear ideas and tools executives can bring back to their organizations. The event also creates space for meaningful networking, allowing l…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…

One foundation. Cross-functional strength. Elevated impact. For years, the question was: What do we build next? More sophisticated AI. More advanced engagement models. Wider access strategies. Each impressive. Each reaching higher. Then market winds shifted. New regulations arrived. Suddenly, the question changed: Can our foundations hold? Walls between functions preventing flexibility. Disconnected data infrastructure fragmenting insights. Inefficiencies becoming liabilities under pressure. Those walls aren't load-bearing, they're removable. That data infrastructure can reinforce decisions. And patient purpose? That's the force binding everything together. You must underpin your customer engagement strategy with reimagined data and infrastructure. You must reprioritise your launch plans t…

The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions including: Device Innovations for Large Volume and Novel Drug Product DeliveryAdvancing Sustainability in the Injectable Device IndustryPrimary Packaging: Ensuring Safe, Stable, and Biocompatible Combination ProductsPatient-Driven Device Design Date and Time: Monday, 27 April 2026 at 08:30 - Wednesday, 29 April 2026 at 17:00